145 related articles for article (PubMed ID: 22993337)
1. Association of matrix metalloproteinase-1 polymorphisms with risk of COPD and lung cancer and survival in lung cancer.
Enewold L; Mechanic LE; Bowman ED; Platz EA; Alberg AJ
Anticancer Res; 2012 Sep; 32(9):3917-22. PubMed ID: 22993337
[TBL] [Abstract][Full Text] [Related]
2. SERPINA1 and ELA2 polymorphisms are not associated with COPD or lung cancer.
Enewold L; Mechanic LE; Bowman ED; Platz EA; Alberg AJ
Anticancer Res; 2012 Sep; 32(9):3923-8. PubMed ID: 22993338
[TBL] [Abstract][Full Text] [Related]
3. Cytokine and cytokine receptor single-nucleotide polymorphisms predict risk for non-small cell lung cancer among women.
Van Dyke AL; Cote ML; Wenzlaff AS; Chen W; Abrams J; Land S; Giroux CN; Schwartz AG
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1829-40. PubMed ID: 19505916
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.
Fang S; Jin X; Wang R; Li Y; Guo W; Wang N; Wang Y; Wen D; Wei L; Zhang J
Carcinogenesis; 2005 Feb; 26(2):481-6. PubMed ID: 15528217
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of matrix metalloproteinases: functional importance in the development of chronic obstructive pulmonary disease?
Wallace AM; Sandford AJ
Am J Pharmacogenomics; 2002; 2(3):167-75. PubMed ID: 12383023
[TBL] [Abstract][Full Text] [Related]
6. PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohort.
Sawa K; Koh Y; Kawaguchi T; Kambayashi S; Asai K; Mitsuoka S; Kimura T; Yoshimura N; Yoshimoto N; Kubo A; Saka H; Matsumura A; Wanibuchi H; Yamamoto N; Nishiyama N; Hirata K
Lung Cancer; 2017 Oct; 112():96-101. PubMed ID: 29191607
[TBL] [Abstract][Full Text] [Related]
7. Genetic abnormalities of the EGFR pathway in African American Patients with non-small-cell lung cancer.
Leidner RS; Fu P; Clifford B; Hamdan A; Jin C; Eisenberg R; Boggon TJ; Skokan M; Franklin WA; Cappuzzo F; Hirsch FR; Varella-Garcia M; Halmos B
J Clin Oncol; 2009 Nov; 27(33):5620-6. PubMed ID: 19786660
[TBL] [Abstract][Full Text] [Related]
8. Admixture mapping of lung cancer in 1812 African-Americans.
Schwartz AG; Wenzlaff AS; Bock CH; Ruterbusch JJ; Chen W; Cote ML; Artis AS; Van Dyke AL; Land SJ; Harris CC; Pine SR; Spitz MR; Amos CI; Levin AM; McKeigue PM
Carcinogenesis; 2011 Mar; 32(3):312-7. PubMed ID: 21115650
[TBL] [Abstract][Full Text] [Related]
9. The relationship between chronic obstructive pulmonary disease and lung cancer in African American patients.
Mina N; Soubani AO; Cote ML; Suwan T; Wenzlaff AS; Jhajhria S; Samarah H; Schwartz AG
Clin Lung Cancer; 2012 Mar; 13(2):149-56. PubMed ID: 22129972
[TBL] [Abstract][Full Text] [Related]
10. Gene-Gene Interactions Between Glutathione S-Transferase M1 and Matrix Metalloproteinases 1, 9, and 12 in Chronic Obstructive Pulmonary Disease in Serbians.
Stankovic M; Nikolic A; Nagorni-Obradovic L; Petrovic-Stanojevic N; Radojkovic D
COPD; 2017 Dec; 14(6):581-589. PubMed ID: 28949773
[TBL] [Abstract][Full Text] [Related]
11. Chronic Obstructive Pulmonary Disease Is Not Associated with KRAS Mutations in Non-Small Cell Lung Cancer.
Saber A; van der Wekken AJ; Kerner GS; van den Berge M; Timens W; Schuuring E; ter Elst A; van den Berg A; Hiltermann TJ; Groen HJ
PLoS One; 2016; 11(3):e0152317. PubMed ID: 27008036
[TBL] [Abstract][Full Text] [Related]
12. Genetic analysis of microsomal epoxide hydrolase gene and its association with lung cancer risk.
Park JY; Chen L; Elahi A; Lazarus P; Tockman MS
Eur J Cancer Prev; 2005 Jun; 14(3):223-30. PubMed ID: 15901990
[TBL] [Abstract][Full Text] [Related]
13. Chronic Obstructive Pulmonary Disease-Related Non-Small-Cell Lung Cancer Exhibits a Low Prevalence of EGFR and ALK Driver Mutations.
Lim JU; Yeo CD; Rhee CK; Kim YH; Park CK; Kim JS; Kim JW; Lee SH; Kim SJ; Yoon HK; Kim TJ; Lee KY
PLoS One; 2015; 10(11):e0142306. PubMed ID: 26555338
[TBL] [Abstract][Full Text] [Related]
14. Racial differences in the association between SNPs on 15q25.1, smoking behavior, and risk of non-small cell lung cancer.
Schwartz AG; Cote ML; Wenzlaff AS; Land S; Amos CI
J Thorac Oncol; 2009 Oct; 4(10):1195-201. PubMed ID: 19641473
[TBL] [Abstract][Full Text] [Related]
15. A review of the Hispanic paradox: time to spill the beans?
Young RP; Hopkins RJ
Eur Respir Rev; 2014 Dec; 23(134):439-49. PubMed ID: 25445942
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in TIMP1 but not MMPs predict excess FEV1 decline in two general population-based cohorts.
van Diemen CC; Postma DS; Siedlinski M; Blokstra A; Smit HA; Boezen HM
Respir Res; 2011 Apr; 12(1):57. PubMed ID: 21524282
[TBL] [Abstract][Full Text] [Related]
17. Racial diversity of actionable mutations in non-small cell lung cancer.
Bollig-Fischer A; Chen W; Gadgeel SM; Wenzlaff AS; Cote ML; Schwartz AG; Bepler G
J Thorac Oncol; 2015 Feb; 10(2):250-5. PubMed ID: 25376516
[TBL] [Abstract][Full Text] [Related]
18. Association of genetic dependences between lung cancer and chronic obstructive pulmonary disease.
Grudny J; Kołakowski J; Kruszewski M; Szopiński J; Sliwiński P; Wiatr E; Winek J; Załęska J; Zych J; Roszkowski-Śliż K
Pneumonol Alergol Pol; 2013; 81(4):308-18. PubMed ID: 23744166
[TBL] [Abstract][Full Text] [Related]
19. Combinations of glutathione S-transferase genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study.
Cote ML; Kardia SL; Wenzlaff AS; Land SJ; Schwartz AG
Carcinogenesis; 2005 Apr; 26(4):811-9. PubMed ID: 15661806
[TBL] [Abstract][Full Text] [Related]
20. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
